AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options, ...

SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (CAPR) (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of ...

This article compares cardiovascular disease risk management in community clinics during the COVID-19 pandemic among patients for whom primary care was delivered mostly in person vs mostly virtually.

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...

Please provide your email address to receive an email when new articles are posted on . Geographic health disparities are multifactorial and present barriers to optimal cardio-obstetrics care.

Heart disease is the number one cause of death for women in the U.S., but women with cardiovascular risk factors often don’t get the treatment they need until it’s too late. In response to emailed ...

NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today ...

Patients undergoing coronary angiography often experience anxiety both before and during the procedure, often treated by the administration of anti-anxiety medications. A new analysis being presented ...

AngioDynamics will provide investors a deeper dive into the cardiovascular technology portfolio and strategic vision. The event will be webcast and can be accessed through the "Investors" section of ...